Tapewire

Nasdaq · USD

ASTH

Astrana Health, Inc.

Export transactions ↓
Tapewire entity
4538
SEC CIK
0001083446
Parsed reports
385

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 11, 2020 Filed Nov 14, 2020 01:07 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $18.20 $0.00
Disclosure

SEC source: 0001250853-20-000098 · primary_doc.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2025-11-11

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from the option grant date.

Read SEC document
September 15, 2020 Filed Apr 7, 2021 01:54 UTC OtherWarrant to Purchase Common Stock · Derivative 68,317 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001250853-21-000048 · primary_doc.xml · derivative · entry 5

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 68,317 shares

Expires 2020-10-14

Read SEC document
September 15, 2020 Filed Apr 7, 2021 01:54 UTC OtherCommon Stock 68,317 $9.00 $614,853.00
Disclosure

SEC source: 0001250853-21-000048 · primary_doc.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,307,214

Read SEC document
September 15, 2020 Filed May 10, 2021 22:04 UTC Amendment OtherCommon Stock 68,317 $9.00 $614,853.00
Disclosure

SEC source: 0001104659-21-064065 · tm2115814-1_4aseq1.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,375,531

F1 · balance_after: This Amendment to Form 4 does not report a new transaction. This Amendment is being filed solely to correct an inadvertent mathematical error in the sum reported for the Amount of Securities Beneficially Owned following the transactions previously reported in the original Form 4 filed on April 6, 2021.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 01:54 UTC
Lam Thomas S.Director · President and Co-CEO
PurchaseCommon Stock 5,000 $17.28 $86,381.00
Disclosure

SEC source: 0001250853-20-000079 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 690,490

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.225 to $17.33, inclusive. The reporting person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

F2 · balance_after: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 01:47 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
PurchaseCommon Stock 1,000 $17.20 $17,204.00
Disclosure

SEC source: 0001250853-20-000078 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By son

Disclosed balance after: 17,379

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.20 to $17.21, inclusive. The Reporting Person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4.

F4 · balance_after: These securities are beneficially owned by Brandon Sim, the Issuer's Chief Technology Officer, interim Co-Chief Operating Officer and Vice President of Engineering, who is the Reporting Person's son and shares the Reporting Person's household. The Reporting Person disclaims any beneficial ownership of these securities.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 01:47 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
PurchaseCommon Stock 5,000 $17.23 $86,168.00
Disclosure

SEC source: 0001250853-20-000078 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T. Sim Pension Plan Trust

Disclosed balance after: 42,996

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.19 to $17.29, inclusive. The Reporting Person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

F2 · balance_after: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 01:34 UTC
Sim BrandonSee Remarks
PurchaseCommon Stock 5,000 $17.23 $86,168.00
Disclosure

SEC source: 0001250853-20-000077 · primary_doc.xml · nonDerivative · entry 2

Sim Brandon · CIK 0001813532 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T. Sim Pension Plan Trust

Disclosed balance after: 42,996

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.19 to $17.29, inclusive. The Reporting Person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.

F3 · balance_after: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 14, 2020 Filed Sep 16, 2020 01:34 UTC
Sim BrandonSee Remarks
PurchaseCommon Stock 1,000 $17.20 $17,204.00
Disclosure

SEC source: 0001250853-20-000077 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,379

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.20 to $17.21, inclusive. The Reporting Person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
September 11, 2020 Filed Sep 15, 2020 23:36 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 602 $18.00 $10,836.00
Disclosure

SEC source: 0001250853-20-000076 · primary_doc.xml · nonDerivative · entry 1

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 471,004

Read SEC document
September 10, 2020 Filed Sep 12, 2020 00:28 UTC
Lam Thomas S.Director · President and Co-CEO
OtherCommon Stock 564,691 $0.00 $0.00
Disclosure

SEC source: 0001250853-20-000072 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 564,691

F1 · kind: On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F3 · ownership.nature: These securities are beneficially owned by the Reporting Person's spouse as separate property pursuant to the transmutation agreement referred to in footnote one. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 10, 2020 Filed Sep 12, 2020 00:28 UTC
Lam Thomas S.Director · President and Co-CEO
OtherCommon Stock 564,691 $0.00 $0.00
Disclosure

SEC source: 0001250853-20-000072 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 685,490

F1 · kind: On September 10, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,691 shares of the Issuer's common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F2 · ownership.nature: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 10, 2020 Filed Sep 15, 2020 00:55 UTC Amendment
Sim Kenneth T.Director · Executive Chairman and Co-CEO
PurchaseCommon Stock 5,000 $17.60 $88,000.00
Disclosure

SEC source: 0001250853-20-000074 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T. Sim Pension Plan Trust

Disclosed balance after: 37,996

F1 · date: The purpose of this amendment is solely to correct a typographical error relating to the transaction date in Table I, Box 2 of the Reporting Person's Form 4. This corrected Form 4 reflects the correct date of September 10, 2020 in Table 1, Box 2 (Transaction Date).

Read SEC document
September 10, 2020 Filed Sep 15, 2020 01:31 UTC
Sim BrandonSee Remarks
PurchaseCommon Stock 5,000 $17.60 $88,000.00
Disclosure

SEC source: 0001250853-20-000075 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T. Sim Pension Plan Trust

Disclosed balance after: 37,996

F1 · balance_after: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 01:25 UTC
Lam Thomas S.Director · President and Co-CEO
PurchaseCommon Stock 5,000 $17.85 $89,250.00
Disclosure

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,814,872

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 09, 2020 Filed Sep 11, 2020 01:10 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
PurchaseCommon Stock 5,000 $17.60 $88,000.00
Disclosure

SEC source: 0001250853-20-000067 · primary_doc.xml · nonDerivative · entry 3

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T. Sim Pension Plan Trust

Disclosed balance after: 37,996

F2 · ownership.nature: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 09, 2020 Filed Sep 10, 2020 22:22 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 7,484 $18.00 $134,712.00
Disclosure

SEC source: 0001250853-20-000066 · primary_doc.xml · nonDerivative · entry 2

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 471,606

Read SEC document
September 09, 2020 Filed Sep 12, 2020 00:14 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
OtherCommon Stock 564,706 $0.00 $0.00
Disclosure

SEC source: 0001250853-20-000071 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wife

Disclosed balance after: 564,706

F1 · kind: On September 9, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,706 shares of Apollo Medical Holdings Inc. common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,706 shares of Apollo Medical Holdings Inc. common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F3 · ownership.nature: These securities are beneficially owned by the Reporting Person's spouse as separate property pursuant to the transmutation agreement referred to in footnote one. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 09, 2020 Filed Sep 12, 2020 00:14 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
OtherCommon Stock 564,706 $0.00 $0.00
Disclosure

SEC source: 0001250853-20-000071 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 641,407

F1 · kind: On September 9, 2020, the Reporting Person and his spouse entered into a transmutation agreement pursuant to which the Reporting Person and his spouse agreed that 564,706 shares of Apollo Medical Holdings Inc. common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of his spouse and 564,706 shares of Apollo Medical Holdings Inc. common stock owned by the Reporting Person and his spouse as community property would be deemed to be the separate property of the Reporting Person.

F2 · ownership.nature: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:25 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionWarrants to Purchase Common Stock · Derivative 63,510 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001250853-20-000068 · primary_doc.xml · derivative · entry 6

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 63,510 shares

Expires 2020-10-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:25 UTC
Lam Thomas S.Director · President and Co-CEO
Tax withholdingCommon Stock 30,252 $18.89 $571,460.28
Disclosure

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,809,872

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:25 UTC
Lam Thomas S.Director · President and Co-CEO
Exercise / conversionCommon Stock 63,510 $9.00 $571,590.00
Disclosure

SEC source: 0001250853-20-000068 · primary_doc.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,840,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:10 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
Exercise / conversionWarrants to Purchase Common Stock · Derivative 63,512 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001250853-20-000067 · primary_doc.xml · derivative · entry 7

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 0

Underlying: Common Stock · 63,512 shares

Expires 2020-10-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:10 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
Tax withholdingCommon Stock 30,253 $18.89 $571,479.17
Disclosure

SEC source: 0001250853-20-000067 · primary_doc.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 1,770,819

F1 · ownership.nature: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 11, 2020 01:10 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
Exercise / conversionCommon Stock 63,512 $9.00 $571,608.00
Disclosure

SEC source: 0001250853-20-000067 · primary_doc.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kenneth T & Simone S Sim Family Trust

Disclosed balance after: 1,801,072

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These securities are held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 22:22 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 5,783 $18.15 $104,949.31
Disclosure

SEC source: 0001250853-20-000066 · primary_doc.xml · nonDerivative · entry 1

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479,090

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.005 to $18.41, inclusive. The reporting person undertakes to provide to Apollo Medical Holdings, Inc., any security holder of Apollo Medical Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 22:46 UTC
Lam Thomas S.Director · President and Co-CEO
PurchaseCommon Stock 5,000 $18.23 $91,150.00
Disclosure

SEC source: 0001104659-20-100935 · tm2029851d1_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,776,614

F1 · price: This transaction was executed in multiple trades at prices ranging from $18.20 to $18.30. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These securities are held by The Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 23:58 UTC
Sim BrandonDirector · See Remarks
PurchaseCommon Stock 5,000 $18.34 $91,700.00
Disclosure

SEC source: 0001104659-20-100971 · tm2029953d2_4.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Indirect · By immediate family member

Disclosed balance after: 1,770,556

F1 · shares: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · shares: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · balance_after: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 27, 2020 Filed Aug 31, 2020 22:18 UTC
Sim Kenneth T.Director · Executive Chairman and Co-CEO
PurchaseCommon Stock 5,000 $18.34 $91,700.00
Disclosure

SEC source: 0001104659-20-100906 · tm2029953d1_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,770,556

F1 · ownership.nature: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 27, 2020 Filed Sep 2, 2020 12:12 UTC Amendment
Sim BrandonSee Remarks, Item 2
PurchaseCommon Stock 5,000 $18.34 $91,700.00
Disclosure

SEC source: 0001553350-20-000821 · ownership.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · See Remarks, Item 2

10b5-1 filing: Not disclosed

Ownership: Indirect · By immediate family member

Disclosed balance after: 1,770,556

F1 · shares: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · shares: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · balance_after: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F1 · ownership.nature: These securities are held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: These securities are beneficially owned by Kenneth T. Sim, the Issuer's Executive Chairman and Co-Chief Executive Officer, who is the Reporting Person's father and shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 15, 2020 Filed Jul 2, 2020 01:40 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to Purchase Common Stock · Derivative 17,534 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001250853-20-000058 · primary_doc.xml · derivative · entry 5

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,534 shares

Expires 2021-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2020 Filed Jul 2, 2020 01:40 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionWarrants to Purchase Common Stock · Derivative 35,069 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001250853-20-000058 · primary_doc.xml · derivative · entry 4

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,069 shares

Expires 2020-10-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2020 Filed Jul 2, 2020 01:40 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 17,534 $10.00 $175,340.00
Disclosure

SEC source: 0001250853-20-000058 · primary_doc.xml · nonDerivative · entry 3

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 15, 2020 Filed Jul 2, 2020 01:40 UTC
Young Albert WaiChowChief Administrative Officer
Exercise / conversionCommon Stock 35,069 $9.00 $315,621.00
Disclosure

SEC source: 0001250853-20-000058 · primary_doc.xml · nonDerivative · entry 2

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,001,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 11, 2020 Filed Jun 13, 2020 00:02 UTC
Chin EricChief Financial Officer
PurchaseCommon Stock 2,040 $14.90 $30,396.00
Disclosure

SEC source: 0001250853-20-000054 · primary_doc.xml · nonDerivative · entry 2

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,197

Read SEC document
June 08, 2020 Filed Jun 9, 2020 17:34 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 4,200 $17.09 $71,778.00
Disclosure

SEC source: 0001250853-20-000053 · primary_doc.xml · nonDerivative · entry 2

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 484,873

Read SEC document
June 05, 2020 Filed Jun 9, 2020 17:34 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 29,185 $17.23 $502,857.55
Disclosure

SEC source: 0001250853-20-000053 · primary_doc.xml · nonDerivative · entry 1

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 489,073

Read SEC document
June 03, 2020 Filed Jun 5, 2020 20:18 UTC
Vazquez AdrianChief Medical Officer
SaleCommon Stock 2,683 $18.00 $48,294.00
Disclosure

SEC source: 0001250853-20-000052 · primary_doc.xml · nonDerivative · entry 1

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,258

Read SEC document
May 26, 2020 Filed May 28, 2020 23:37 UTC
Ang HingChief Operating Officer
Disposition to issuerCommon Stock 2,444 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-067225 · tm2021314d1_4.xml · nonDerivative · entry 1

Ang Hing · CIK 0001725087 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,316

F1 · shares: Reflects the forfeiture of restricted shares of the Issuer's common stock granted to the Reporting Person on February 5, 2020 under the Issuer's 2015 Equity Incentive Plan that were unvested as of May 26, 2020, the date that the Reporting Person resigned as the Issuer's Chief Operating Officer.

Read SEC document
May 06, 2020 Filed May 21, 2020 19:44 UTC
Fawcett MarkDirector
Disposition to issuerStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0001104659-20-064720 · tm2020664d1_form4.xml · derivative · entry 2

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,909

Underlying: Common Stock · 20,000 shares

Expires 2026-09-14

F1 · derivative.exercise_date: These stock options were granted on September 14, 2016, and vested and became exercisable in twelve equal monthly installments commencing on October 14, 2016.

Read SEC document
May 06, 2020 Filed May 21, 2020 19:44 UTC
Fawcett MarkDirector
Exercise / conversionCommon Stock 20,000 $5.00 $100,000.00
Disclosure

SEC source: 0001104659-20-064720 · tm2020664d1_form4.xml · nonDerivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2020 Filed Jun 13, 2020 00:02 UTC
Chin EricChief Financial Officer
Tax withholdingCommon Stock 555 $12.92 $7,170.60
Disclosure

SEC source: 0001250853-20-000054 · primary_doc.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,157

F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2020.

Read SEC document
March 31, 2020 Filed Jul 2, 2020 01:40 UTC
Young Albert WaiChowChief Administrative Officer
Tax withholdingCommon Stock 256 $12.92 $3,307.52
Disclosure

SEC source: 0001250853-20-000058 · primary_doc.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 966,040

F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2020.

Read SEC document
March 04, 2020 Filed Mar 13, 2023 16:40 UTC
Dong LindaDirector
GrantStock Option (right to buy) · Derivative 62,500 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 4

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2023-04-05

F2 · kind: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

F2 · price: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

F2 · derivative.exercise_date: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

Read SEC document
March 04, 2020 Filed Mar 13, 2023 16:40 UTC
Dong LindaDirector
Disposition to issuerStock Option (right to buy) · Derivative 62,500 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001250853-23-000009 · primary_doc.xml · derivative · entry 3

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires 2020-04-05

F2 · kind: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

F2 · price: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

F2 · derivative.exercise_date: The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 22:13 UTC
Ang HingChief Operating Officer
GrantCommon Stock 3,666 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-012615 · tm207161d6_4.xml · nonDerivative · entry 1

Ang Hing · CIK 0001725087 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,259

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 22:12 UTC
Chin EricCFO & Corporate Secretary
GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-012613 · tm207161d5_4.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · CFO & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,712

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 22:12 UTC
Young Albert WaiChowChief Administrative Officer
GrantCommon Stock 1,880 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-012612 · tm207161d4_4.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 918,326

F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 22:09 UTC Amendment
Chin EricCFO & Corporate Secretary
OtherCommon Stock 4,083 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-012607 · tm207161d2_4a.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · CFO & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,639

F1 · kind: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · acquired: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 22:09 UTC Amendment
Ang HingChief Operating Officer
OtherCommon Stock 3,674 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-012608 · tm207161d3_4a.xml · nonDerivative · entry 1

Ang Hing · CIK 0001725087 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,593

F1 · kind: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · acquired: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.